Key Takeaways:Beiersdorf accelerates innovation building on successful corporate venture capital activities launched in 2020.The second-generation Skin Care Innovation Fund has €100 million ($114 million) committed.The fund will focus on investments and strategic collaborations with pioneering startups in life sciences, sustainability, AI, and digital health at the intersection of skincare.Beiersdorf is doubling down on venture capital as a strategic lever to drive future growth through science-based innovation.WHO: Beiersdorf Venture Capital (BVC) is the corporate venture capital arm of Beiersdorf AG, one of the world’s leading skincare companies and home to brands including Nivea, Eucerin, and La Prairie. BVC invests in innovative startups globally from seed to Series B across strategically relevant fields, including life sciences, sustainability, AI, and digital health solutions. In addition to capital investments, Beiersdorf seeks to jointly pioneer the future of skincare while creating mutual value through strategic collaboration and technology partnerships. By connecting the scientific depth, global scale, and market access of Beiersdorf with the agility and innovation of startups, BVC aims to accelerate breakthrough technologies from the laboratory to the consumer.The new Skin Care Innovation Fund doubles the volume of the fund launched in 2020 and reinforces Beiersdorf’s ambition to lead innovation in skincare, launching the second generation of its corporate venture capital fund with a €100 million ($114 million) commitment.